Literature DB >> 10993643

Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.

Y Maehara1, Y Kakeji, S Oda, I Takahashi, K Akazawa, K Sugimachi.   

Abstract

The incidence of gastric cancer is much higher in Japan than in other countries even though diagnostics and treatments of such patients have improved. The objective of this study was to present an overview of the past, present and future of surgical treatment for our patients with gastric cancer. We analysed data on 2152 Japanese men and women with gastric cancer who underwent surgical resection from 1965 to 1995 at Kyushu University in Fukuoka, Japan, based on a univariate and the multivariate analysis. We focused on time trends of surgical treatment and the postoperative outcome. Over the years, there have been favourable changes in the numbers of patients with early gastric cancer. In all cases of gastric cancer, the rate of 18% in the first six year period (group 1) was 57% in the last 5 year period (group 6). Size of the tumour was smaller, well-differentiated tumour tissue was more common, and lymphatic involvement was less frequent. Lymph node metastasis, liver metastasis and peritoneal dissemination all decreased. Extensive lymph node dissection was more frequently done and the rate of curative resection (curability A and B) increased. With increases in identifying the early stage of cancer and better perioperative care, mortality rates 30 days after the surgery greatly decreased. Multivariate analysis revealed that the 10 factors of depth of invasion, lymph node metastasis, lymph node dissection, tumour size, liver metastasis, peritoneal dissemination, lymphatic invasion, vascular invasion, lesion in the whole stomach and lesion in the middle stomach were independent factors for determining the prognosis. Detection of the tumour in an early stage, standardized surgical treatment, including routine lymph node dissection, close follow-up schedules and better perioperative management are expected to increase survival time for patients with this malignancy. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2000        PMID: 10993643      PMCID: PMC2363551          DOI: 10.1054/bjoc.2000.1427

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  43 in total

Review 1.  Radical surgery for gastric cancer. A review of the Japanese experience.

Authors:  Y Noguchi; T Imada; A Matsumoto; D G Coit; M F Brennan
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

2.  Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time.

Authors:  Y Maehara; T Okuyama; S Moriguchi; H Orita; H Kusumoto; D Korenaga; K Sugimachi
Journal:  Cancer       Date:  1992-07-15       Impact factor: 6.860

3.  Surgical treatment and outcome for node-negative gastric cancer.

Authors:  Y Maehara; M Tomoda; S Tomisaki; M Ohmori; H Baba; K Akazawa; K Sugimachi
Journal:  Surgery       Date:  1997-06       Impact factor: 3.982

4.  Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis.

Authors:  T Okamura; S Tsujitani; D Korenaga; M Haraguchi; H Baba; Y Hiramoto; K Sugimachi
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

5.  D1 versus D2 dissection for gastric cancer.

Authors:  S Guadagni; M Catarci; G de Manzoni; T Kinoshita
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

6.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

7.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

Review 8.  Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers.

Authors:  N P Alazraki; D Eshima; L A Eshima; S C Herda; D R Murray; J P Vansant; A T Taylor
Journal:  Semin Nucl Med       Date:  1997-01       Impact factor: 4.446

9.  Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence.

Authors:  Y Maehara; T Oshiro; K Endo; H Baba; S Oda; Y Ichiyoshi; S Kohnoe; K Sugimachi
Journal:  Surgery       Date:  1996-04       Impact factor: 3.982

10.  Prognostic factors in adenocarcinoma in the upper one-third of the stomach.

Authors:  Y Maehara; S Moriguchi; Y Kakeji; H Orita; M Haraguchi; D Korenaga; K Sugimachi
Journal:  Surg Gynecol Obstet       Date:  1991-09
View more
  39 in total

1.  Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer.

Authors:  Eiji Nomura; Sang-Woong Lee; George Bouras; Takaya Tokuhara; Michihiro Hayashi; Masako Hiramatsu; Jyunji Okuda; Nobuhiko Tanigawa
Journal:  Gastric Cancer       Date:  2011-04-26       Impact factor: 7.370

2.  β-Shaped intracorporeal Roux-en-Y reconstruction after totally laparoscopic distal gastrectomy.

Authors:  Kazuo Motoyama; Kazuyuki Kojima; Mikiko Hayashi; Keiji Kato; Mikito Inokuchi; Kenichi Sugihara
Journal:  Gastric Cancer       Date:  2013-11-01       Impact factor: 7.370

3.  Clinicopathological features and trend changes of gastric carcinoma in Southern China.

Authors:  Jian-Jun Peng; Ping Xiao; Jian-Bo Xu; Wu Song; Bing Liao; Yu-Long He
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach.

Authors:  Xiaohua Jiang; Naoki Hiki; Souya Nunobe; Kyoko Nohara; Koshi Kumagai; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Gastric Cancer       Date:  2011-02-24       Impact factor: 7.370

5.  Evaluation of the adequacy of lymph node dissection in pylorus-preserving gastrectomy for early gastric cancer using the maruyama index.

Authors:  Moon-Won Yoo; Do Joong Park; Hye Seong Ahn; Sang-Ho Jeong; Hyuk-Joon Lee; Woo Ho Kim; Hyung-Ho Kim; Kuhn Uk Lee; Han-Kwang Yang
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

6.  Characteristics of synchronous cancers in gastric cancer patients.

Authors:  Ja Seong Bae; Jun Ho Lee; Keun Won Ryu; Young Woo Kim; Jae Moon Bae
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

7.  Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size.

Authors:  Chen Li; Sung Jin Oh; Sungsoo Kim; Woo Jin Hyung; Min Yan; Zheng Gang Zhu; Sung Hoon Noh
Journal:  J Gastrointest Surg       Date:  2009-01-31       Impact factor: 3.452

8.  Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients.

Authors:  Shao-Hua Ge; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Fang Xing; Lian-Hai Zhang; Yu-Bing Zhu; Hong Du; Bin Dong; Ying Hu; Jia-Fu Ji
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

9.  Expression of tumor related gene NAG6 in gastric cancer and restriction fragment length polymorphism analysis.

Authors:  Xiao-Mei Zhang; Shou-Rong Sheng; Xiao-Yan Wang; Liang-Hua Bin; Jie-Ru Wang; Gui-Yuan Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

10.  Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution.

Authors:  Woo Jin Hyung; Sung Soo Kim; Won Hyuk Choi; Jae Ho Cheong; Seung Ho Choi; Choong Bai Kim; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.